惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
Apple Machine Learning Research
Apple Machine Learning Research
aimingoo的专栏
aimingoo的专栏
H
Help Net Security
腾讯CDC
T
Tailwind CSS Blog
Hugging Face - Blog
Hugging Face - Blog
人人都是产品经理
人人都是产品经理
酷 壳 – CoolShell
酷 壳 – CoolShell
MongoDB | Blog
MongoDB | Blog
宝玉的分享
宝玉的分享
有赞技术团队
有赞技术团队
美团技术团队
雷峰网
雷峰网
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
博客园 - 司徒正美
博客园_首页
Recent Announcements
Recent Announcements
云风的 BLOG
云风的 BLOG
B
Blog RSS Feed
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
D
Docker
博客园 - Franky
Jina AI
Jina AI

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Krystal Biotech, Inc. (KRYS) Q1 2026 Earnings Call Transc...
2026-05-05 · via All Articles on Seeking Alpha

Krystal Biotech, Inc. (KRYS) Q1 2026 Earnings Call May 4, 2026 8:30 AM EDT

Company Participants

Stephane Paquette - Senior Vice President of Corporate Development
Krish Krishnan - Founder, Chairman, President & CEO
Laurent Goux - Executive VP & Head of International
Christine Wilson - Senior VP & Head of US Commercial
Suma Krishnan - Founder, President of R&D and Director
Kathryn Romano - Executive VP & Chief Accounting Officer

Conference Call Participants

Jiale Song - Jefferies LLC, Research Division
Matthew Guggenbiller - BofA Securities, Research Division
Joseph Pantginis - H.C. Wainwright & Co, LLC, Research Division
Ritu Baral - TD Cowen, Research Division
Yigal Nochomovitz - Citigroup Inc., Research Division
William Maughan - Clear Street LLC., Research Division
Gavin Clark-Gartner - Evercore ISI Institutional Equities, Research Division
Joshua Soto Ocana

Presentation

Operator

Thank you for standing by, and welcome to the Krystal Biotech First Quarter 2026 Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded.

I would now like to hand the conference over to your host, Stephane Paquette, Vice President of Corporate Development. Please begin.

Stephane Paquette
Senior Vice President of Corporate Development

Good morning, and thank you all for joining today's call. Earlier today, we released our financial results for the first quarter of 2026. The press release is available on our website at www.krystalbio.com. We also filed our earnings 8-K and 10-Q with the SEC earlier today.

Joining me today will be Krish Krishnan, Chairman and Chief Executive Officer; Suma Krishnan, President of Research and Development; Laurent Goux, Executive Vice President and General Manager for Europe; Christine Wilson, Senior Vice President and Head of U.S. Commercial; and Kate Romano, Chief Accounting Officer.

This conference call will and our responses to questions may contain forward-looking statements. You are cautioned not to rely on these forward-looking statements, which are based on current expectations and information available as